Christoph Lengauer

Insider Reports History

Entity
Individual
Location
Blueprint Medicines Corp., 215 First Street, Suite 340/350, Cambridge, MA
Signature
/s/ Reinhard Kandera, as Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Christoph Lengauer:

Stock Role Class Num Shares Value Price $ Report Date Ownership
HOOKIPA Pharma Inc. Director Stock Option (Right to Buy) 9.6K Jun 1, 2021 Direct

Insider Reports Filed by Christoph Lengauer

Symbol Company Period Transactions Value $ Form Type Date Filed Role
HOOK HOOKIPA Pharma Inc. Jun 1, 2021 1 $0 4 Jun 4, 2021 Director